The Effects of a 12-week Block Periodization vs. Daily Undulating Periodization on Muscular Strength and Cognitive Function in Healthy Young Adults.

This study compared the effects of two resistance training periodization models, block periodization and daily undulating periodization, on muscular strength and force production in healthy young adults with limited resistance training experience. Participants were randomly assigned to a block periodization group, a daily undulating periodization group, or a non-training control group. The two training groups completed three supervised resistance training sessions per week for 12 weeks. Both training programs used the same exercises and were designed to have similar total training volume and average programmed relative intensity, but differed in how training volume and intensity were organized over time. Muscular strength and force production were assessed before and after the intervention using the isometric mid-thigh pull and single-joint isometric strength testing of the knee and elbow.

Study Overview

Detailed Description

This was a randomized, controlled, parallel-group study designed to compare the effects of block periodization (BP) and daily undulating periodization (DUP) on maximal and rapid isometric force production in healthy young adults.

Participants were randomly assigned to one of three groups: block periodization, daily undulating periodization, or a non-training control group. The intervention lasted 12 weeks. Participants in both resistance training groups completed three supervised training sessions per week, for a total of 36 planned sessions.

The BP and DUP groups performed the same resistance exercises and were programmed to complete equivalent total training volume and similar average programmed relative intensity across the 12-week intervention. The principal difference between the groups was the temporal organization of training volume and intensity. In the BP group, training was organized into sequential three-week blocks emphasizing different loading characteristics. In the DUP group, loading variables were varied more frequently between training sessions within each weekly microcycle.

Before and after the 12-week intervention, participants completed assessments of muscular strength and force production. Maximal and rapid force production were assessed using the isometric mid-thigh pull (IMTP), including peak force and force produced at 150, 200, and 250 milliseconds after contraction onset. Single-joint isometric strength of the knee flexors and extensors and elbow flexors and extensors was assessed using a Biodex System 4 Pro dynamometer. Body mass and body composition were also assessed.

The purpose of the study was to determine whether differences in the organization of resistance training, when exercise selection, total training volume, and average programmed relative intensity were controlled, resulted in different adaptations in maximal and rapid force production.In addition, cognitive function was assessed at the beginning and end of the 12-week intervention using the Stroop test.

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gdansk, Poland
        • University of Physical Education and Sport

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria for the training group:

  • 0-2,5 years of strength training experience
  • between the ages of 18 and 35
  • without chronic diseases that would preclude resistance training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Block Periodization (BP)

Participants completed a 12-week supervised block-periodized resistance training program consisting of three training sessions per week. Training was organized into sequential three-week blocks with systematic changes in training volume and relative intensity. Exercise selection, total programmed training volume, and average programmed relative intensity across the intervention were matched to the Daily Undulating Periodization group.

Participants completed a 12-week supervised block periodization resistance training program with three sessions per week. Training was organized into four consecutive three-week blocks. The programmed relative intensities across the four blocks were approximately 70%, 83%, 78%, and 90% of estimated 1RM, respectively, with corresponding changes in sets and repetitions. Exercise selection, total programmed training volume, and average programmed relative intensity across the 12-week intervention were matched to the Daily Undulating Periodization group. Loads were individually adjusted based on performance and repetitions in reserve (RIR).

Other Names:
  • BP
Active Comparator: Daily Undulating Periodization (DUP)

Participants completed a 12-week supervised daily undulating resistance training program consisting of three training sessions per week. Training volume and relative intensity varied between training sessions within each weekly microcycle. Exercise selection, total programmed training volume, and average programmed relative intensity across the intervention were matched to the Block Periodization group.

Participants completed a 12-week supervised daily undulating periodization resistance training program with three sessions per week. Training volume and relative intensity varied between sessions within each weekly microcycle, using loading conditions corresponding to approximately 70%, 78%, 83%, and 90% of estimated 1RM across the intervention. Exercise selection, total programmed training volume, and average programmed relative intensity across the 12-week intervention were matched to the Block Periodization group. Loads were individually adjusted based on performance and repetitions in reserve (RIR).

Other Names:
  • DUP
No Intervention: Control (CON)

Participants did not participate in the resistance training intervention and were instructed to maintain their usual physical activity throughout the 12-week study period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
maximal and rapid force production characteristics derived from the IMTP, including net peak force and force expressed at 150-, 200-, and 250 ms
Time Frame: At the start and end of the 12-week intervention
At the start and end of the 12-week intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Omega-3 assessments
Time Frame: At the beginning and at the end of the 12-week training period

Assessment of fatty acids: EPA, DHA; omega-3 index, AA/EPA, omega-6: omega-3 in erythrocytes of participants.

At the beginning and at the end of the 12-week training period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2023

Primary Completion (Actual)

June 2, 2024

Study Completion (Actual)

June 26, 2024

Study Registration Dates

First Submitted

September 28, 2026

First Submitted That Met QC Criteria

October 2, 2026

First Posted (Actual)

October 6, 2026

Study Record Updates

Last Update Posted (Actual)

October 6, 2026

Last Update Submitted That Met QC Criteria

October 2, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • AWFiS/2025_2_MK

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe